135 related articles for article (PubMed ID: 8514709)
1. Pulmonary and systemic vascular responsiveness to TNF-alpha in conscious rats.
Stevens T; Morris K; McMurtry IF; Zamora M; Tucker A
J Appl Physiol (1985); 1993 Apr; 74(4):1905-10. PubMed ID: 8514709
[TBL] [Abstract][Full Text] [Related]
2. NG-monomethyl-L-arginine does not restore loss of hypoxic pulmonary vasoconstriction induced by TNF-alpha.
Johnson D; Hurst T; Wilson T; Murphy F; Saxema A; To T; Mayers I
J Appl Physiol (1985); 1993 Aug; 75(2):618-25. PubMed ID: 8226460
[TBL] [Abstract][Full Text] [Related]
3. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure.
Hampl V; Archer SL; Nelson DP; Weir EK
J Appl Physiol (1985); 1993 Oct; 75(4):1748-57. PubMed ID: 7506706
[TBL] [Abstract][Full Text] [Related]
4. Action of carbon dioxide on hypoxic pulmonary vasoconstriction in the rat lung: evidence against specific endothelium-derived relaxing factor-mediated vasodilation.
Baudouin SV; Evans TW
Crit Care Med; 1993 May; 21(5):740-6. PubMed ID: 8482095
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term TNF-alpha administration increases pulmonary vascular reactivity in isolated rat lungs.
Stevens T; Janssen PL; Tucker A
J Appl Physiol (1985); 1992 Aug; 73(2):708-12. PubMed ID: 1400001
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats.
Liu SF; Crawley DE; Barnes PJ; Evans TW
Am Rev Respir Dis; 1991 Jan; 143(1):32-7. PubMed ID: 1986681
[TBL] [Abstract][Full Text] [Related]
7. Relative contribution of endothelium-derived relaxation factor to vascular tone in the systemic, pulmonary, and cerebral circulations of piglets.
Rudinsky B; Bell A; Hipps R; Meadow W
Dev Pharmacol Ther; 1993; 20(3-4):152-61. PubMed ID: 7828447
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary vascular reactivity to endothelin-1 in normal and chronically pulmonary hypertensive rats.
Eddahibi S; Raffestin B; Braquet P; Chabrier PE; Adnot S
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S358-61. PubMed ID: 1725380
[TBL] [Abstract][Full Text] [Related]
9. Influence of N omega-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation.
Feng CJ; Cheng DY; Kaye AD; Kadowitz PJ; Nossaman BD
Eur J Pharmacol; 1994 Sep; 263(1-2):133-40. PubMed ID: 7821344
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha augments pulmonary vasoconstriction via the inhibition of nitrovasodilator activity.
Johnson A; Ferro TJ
J Appl Physiol (1985); 1992 Dec; 73(6):2483-92. PubMed ID: 1490962
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation.
Brashers VL; Peach MJ; Rose CE
J Clin Invest; 1988 Nov; 82(5):1495-502. PubMed ID: 3263394
[TBL] [Abstract][Full Text] [Related]
12. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs.
Oka M; Hasunuma K; Webb SA; Stelzner TJ; Rodman DM; McMurtry IF
Am J Physiol; 1993 Jun; 264(6 Pt 1):L587-97. PubMed ID: 8333550
[TBL] [Abstract][Full Text] [Related]
13. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo.
Persson MG; Gustafsson LE; Wiklund NP; Moncada S; Hedqvist P
Acta Physiol Scand; 1990 Dec; 140(4):449-57. PubMed ID: 1707210
[TBL] [Abstract][Full Text] [Related]
14. Effects of TNF-alpha on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs.
Mitaka C; Hirata Y; Ichikawa K; Yokoyama K; Emori T; Kanno K; Amaha K
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1530-6. PubMed ID: 7943398
[TBL] [Abstract][Full Text] [Related]
15. Unaltered vasoconstrictor responsiveness after iNOS inhibition in lungs from chronically hypoxic rats.
Resta TC; O'Donaughy TL; Earley S; Chicoine LG; Walker BR
Am J Physiol; 1999 Jan; 276(1):L122-30. PubMed ID: 9887064
[TBL] [Abstract][Full Text] [Related]
16. The effects of intravenous L-arginine supplementation on systemic and pulmonary hemodynamics and oxygen utilization during group B streptococcal sepsis in piglets.
Rudinsky B; Bell A; Hipps R; Meadow W
J Crit Care; 1994 Mar; 9(1):34-46. PubMed ID: 8199652
[TBL] [Abstract][Full Text] [Related]
17. Flow-induced release of EDRF in the pulmonary vasculature: site of release and action.
Hakim TS
Am J Physiol; 1994 Jul; 267(1 Pt 2):H363-9. PubMed ID: 8048602
[TBL] [Abstract][Full Text] [Related]
18. The effect of prolonged inhaled nitric oxide on pulmonary vasoconstriction in rats.
Frank DU; Horstman DJ; Rich GF
Anesth Analg; 1998 Dec; 87(6):1285-90. PubMed ID: 9842814
[TBL] [Abstract][Full Text] [Related]
19. EDRF inhibition augments pulmonary hypertension in intact newborn lambs.
Fineman JR; Chang R; Soifer SJ
Am J Physiol; 1992 May; 262(5 Pt 2):H1365-71. PubMed ID: 1590440
[TBL] [Abstract][Full Text] [Related]
20. Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats.
Roos CM; Frank DU; Xue C; Johns RA; Rich GF
J Appl Physiol (1985); 1996 Jan; 80(1):252-60. PubMed ID: 8847312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
